Top Midday Decliners

MT Newswires Live11-11

Lazydays Holdings (GORV) disclosed late Friday its intention to delist its common stock from the Nasdaq Capital Market and anticipates the delisting will become effective on or about Nov. 28.

Shares dropped 40%, with intraday trading volume at over 535,000 versus the stock's daily average of about 1.01 million.

Carbon Revolution (CREV) said late Friday that it intends to appeal the Nasdaq's decision to delist its shares because of the company's non-compliance with the exchange's minimum shareholders' equity rule and failure to file its annual report.

Carbon Revolution plans to present a compliance plan to address deficiencies and request an extension to regain compliance, with the appeal potentially delaying suspension until at least Nov. 28, according to the company.

Shares were 27% lower, with intraday trading volume at over 133,000 versus the stock's daily average of roughly 466,000.

B. Riley downgraded Applied Optoelectronics (AAOI) to sell from neutral, while maintaining its price target of $15.

Late Friday, the company said it may issue and sell up to $180 million of its shares from time to time.

Shares slumped 11% as intraday trading volume soared to about 7.64 million from a daily average of about 5.27 million.

Price: 0.96, Change: -0.65, Percent Change: -40.19

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment